Webster Bank, N. A. Bristol Myers Squibb CO Transaction History

Webster Bank, N. A.

$932 Million
Q3 2024

A detailed history of Webster Bank, N. A. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Webster Bank, N. A. holds 21,937 shares of BMY stock, worth $1.24 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

21,937

Previous 23,092 5.0%

Holding current value

$1.24 Million

Previous $959,000 18.35%

% of portfolio

0.12%

Previous 0.11%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$39.66 - $51.75 $45,807 - $59,771	-1,155 Reduced 5.0%	21,937 $1.14 Million
Q2 2024 Jul 12, 2024	SELL	$40.25 - $52.99 $104,972 - $138,197	-2,608 Reduced 10.15%	23,092 $959,000
Q1 2024 Apr 16, 2024	SELL	$47.98 - $54.4 $50,091 - $56,793	-1,044 Reduced 3.9%	25,700 $1.39 Million
Q4 2023 Jan 23, 2024	SELL	$48.48 - $57.85 $10,859 - $12,958	-224 Reduced 0.83%	26,744 $1.37 Million
Q3 2023 Oct 10, 2023	SELL	$57.89 - $64.73 $31,318 - $35,018	-541 Reduced 1.97%	26,968 $1.57 Million
Q2 2023 Jul 13, 2023	SELL	$63.71 - $70.74 $402,264 - $446,652	-6,314 Reduced 18.67%	27,509 $1.76 Million
Q1 2023 Apr 13, 2023	SELL	$65.71 - $74.53 $82,991 - $94,131	-1,263 Reduced 3.6%	33,823 $2.34 Million
Q4 2022 Jan 18, 2023	SELL	$68.48 - $81.09 $22,940 - $27,165	-335 Reduced 0.95%	35,086 $2.53 Million
Q3 2022 Oct 24, 2022	BUY	$0.13 - $76.84 $16 - $9,989	130 Added 0.37%	35,421 $2.52 Million
Q2 2022 Jul 12, 2022	SELL	$72.62 - $79.98 $23,238 - $25,593	-320 Reduced 0.9%	35,291 $2.72 Million
Q1 2022 Apr 13, 2022	SELL	$61.48 - $73.72 $1.24 Million - $1.48 Million	-20,105 Reduced 36.08%	35,611 $2.6 Million
Q4 2021 Jan 12, 2022	SELL	$53.63 - $62.52 $981,429 - $1.14 Million	-18,300 Reduced 24.72%	55,716 $3.47 Million
Q3 2021 Oct 12, 2021	SELL	$59.17 - $69.31 $75,678 - $88,647	-1,279 Reduced 1.7%	74,016 $4.38 Million
Q2 2021 Jul 20, 2021	BUY	$61.91 - $67.42 $21,978 - $23,934	355 Added 0.47%	75,295 $5.03 Million
Q1 2021 May 07, 2021	SELL	$59.34 - $66.74 $9,850 - $11,078	-166 Reduced 0.22%	74,940 $4.73 Million
Q4 2020 Jan 07, 2021	SELL	$57.74 - $65.43 $37,126 - $42,071	-643 Reduced 0.85%	75,106 $4.66 Million
Q3 2020 Oct 22, 2020	BUY	$57.43 - $63.64 $53,697 - $59,503	935 Added 1.25%	75,749 $4.57 Million
Q2 2020 Jul 09, 2020	BUY	$54.82 - $64.09 $52,572 - $61,462	959 Added 1.3%	74,814 $4.4 Million
Q1 2020 Apr 21, 2020	SELL	$46.4 - $67.43 $89,180 - $129,600	-1,922 Reduced 2.54%	73,855 $4.12 Million
Q4 2019 Jan 14, 2020	BUY	$49.21 - $64.19 $48,324 - $63,034	982 Added 1.31%	75,777 $4.87 Million
Q3 2019 Oct 02, 2019	SELL	$42.77 - $50.71 $65,694 - $77,890	-1,536 Reduced 2.01%	74,795 $3.79 Million
Q2 2019 Jul 11, 2019	SELL	$44.62 - $49.34 $126,408 - $139,780	-2,833 Reduced 3.58%	76,331 $3.46 Million
Q1 2019 Apr 10, 2019	BUY	$45.12 - $53.8 $330,097 - $393,600	7,316 Added 10.18%	79,164 $3.78 Million
Q4 2018 Jan 09, 2019	SELL	$48.76 - $63.23 $533,970 - $692,431	-10,951 Reduced 13.23%	71,848 $3.74 Million
Q3 2018 Oct 12, 2018	SELL	$55.19 - $62.25 $105,302 - $118,773	-1,908 Reduced 2.25%	82,799 $5.14 Million
Q2 2018 Jul 12, 2018	SELL	$50.53 - $62.98 $71,045 - $88,549	-1,406 Reduced 1.63%	84,707 $4.69 Million
Q1 2018 Apr 19, 2018	BUY	$59.92 - $68.98 $75,619 - $87,052	1,262 Added 1.49%	86,113 $5.45 Million
Q4 2017 Jan 23, 2018	SELL	$59.94 - $65.35 $63,176 - $68,878	-1,054 Reduced 1.23%	84,851 $5.2 Million
Q3 2017 Oct 12, 2017	BUY	$55.23 - $63.74 $4.74 Million - $5.48 Million	85,905	85,905 $5.48 Million

Others Institutions Holding BMY

# of Institutions

2,535

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Webster Bank, N. A., based on Form 13F filings with the SEC.

News

Stay updated on Webster Bank, N. A. with notifications on news.

Account